$CSBR· SEC filing ·

CSBR Reports $15M Q2 Revenue, 11% Growth, $237K Net Income, 52% Oncology Services Margin

Champions Oncology, Inc. · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $5.84

Post-detection moves

1h
1d
3d
7d
30d

Get alerts like this in real time

Push notifications the moment a signal fires. No spam, no crypto, no fluff.

Download for iOS